Pernilla Sandwall
Director/Board Member bei Innovativa Mindre Life Science
Profil
Pernilla Sandwall currently works at InDex Diagnostics AB, as Director and Innovativa Mindre Life Science, as Director from 2012.
Ms. Sandwall also formerly worked at Wntresearch AB, as Chief Executive Officer, Alzinova AB, as Independent Director, InDex Pharmaceuticals AB, as Chief Operating Officer & Director from 2012 to 2022, Merck & Co., Inc., as Project Manager from 2004 to 2012, and InDex Pharmaceuticals Holding AB, as Chief Operating Officer from 2012 to 2022.
Ms. Sandwall received her graduate degree from the University of Uppsala.
Aktive Positionen von Pernilla Sandwall
| Unternehmen | Position | Beginn |
|---|---|---|
Innovativa Mindre Life Science
 Innovativa Mindre Life Science Miscellaneous Commercial ServicesCommercial Services Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology. | Director/Board Member | 01.01.2012 |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The private company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Director/Board Member | - |
Ehemalige bekannte Positionen von Pernilla Sandwall
| Unternehmen | Position | Ende |
|---|---|---|
| WNTRESEARCH AB | Chief Executive Officer | 10.01.2024 |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Chief Operating Officer | 29.04.2022 |
| INDEX PHARMACEUTICALS HOLDING AB | Chief Operating Officer | 01.04.2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2012 |
| ALZINOVA AB | Director/Board Member | - |
Ausbildung von Pernilla Sandwall
| University of Uppsala | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| WNTRESEARCH AB | Health Technology |
| ALZINOVA AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
InDex Diagnostics AB
InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The private company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Health Technology |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Health Technology |
Innovativa Mindre Life Science
Innovativa Mindre Life Science Miscellaneous Commercial ServicesCommercial Services Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology. | Commercial Services |
